Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pancreatic Neoplasms 8 Liver Neoplasms 5 Carcinoma, Hepatocellular 4 Lung Neoplasms 3 Squamous Intraepithelial Lesions 2 Prostatic Neoplasms 2 Uterine Cervical Neoplasms 1 Uterine Cervical Dysplasia 1 Urinary Bladder Neoplasms 1 Ureteral Neoplasms 1 Unresectable Pancreatic Cancer 1 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Small Cell Lung Carcinoma 1 Skin Neoplasms 1 Rectal Neoplasms 1 Pancreatic Ductal Adenocarcinoma 1 Neoplasm Metastasis 1 Melanoma 1 Lymphatic Metastasis 1 Liver, Cancer of, Non-Resectable 1 Laryngeal Neoplasms 1 Hilus Pulmonary Neoplasms 1 Head and Neck Neoplasms 1 HIV Seropositivity 1 Gallbladder Neoplasms 1 Extremities Neoplasms 1 Esophageal Neoplasms 1 Colorectal Liver Metastases 1 Carcinoma, Renal Cell 1

Interventions

Cisplatin 72 Brachytherapy 31 Radiotherapy 26 Paclitaxel 23 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 21 human papillomavirus vaccine, L1 type 16, 18 20 Topotecan 18 Papillomavirus Vaccines 18 Carboplatin 18 Surveys and Questionnaires 17 Bevacizumab 16 pembrolizumab 14 Radiation 12 Gemcitabine 12 Early Intervention, Educational 12 Colposcopy 12 Methods 11 Magnetic Resonance Spectroscopy 11 atezolizumab 10 Radiotherapy, Intensity-Modulated 10 Blood Specimen Collection 10 Papanicolaou Test 9 Docetaxel 9 Vaccines, Synthetic 8 Platinum 8 Nivolumab 8 Ipilimumab 8 Counseling 8 1,2-diaminocyclohexaneplatinum II citrate 8 Vaccines 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Uterine Cervical Neoplasms × Electroporation × Clear all

NCT02430610 2021-09-05

IRE

Fuda Cancer Hospital, Guangzhou

Phase NA Completed

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡